PTPRC and chronic obstructive pulmonary disease: We profiled peripheral human lung samples from 11 donors (4 wild-type “MM” COPD, 2 ZZ-AATD, 5 “MM” control participants without chronic lung disease) by single-cell RNA sequencing after CD45 reduction (Fig 1A).